Private medical detox for Delray Beach — 0 minutes, then straight into treatment.

RECO Island's Delray Beach campus sits inside city limits — 0 miles from Pineapple Grove and Lake Ida — so a medical detox admission does not require leaving the community that supports recovery. Small-census, physician-led, nurse-staffed 24/7, with CIWA-Ar and COWS symptom-triggered protocols run at bedside rather than fixed-dose tapers. The detox unit and the residential program share one clinical team and one campus, so day six of detox and day one of residential are continuous — same primary therapist, same treatment plan, no third-party handoff, no waitlist.

RECO Island’s Delray Beach detox and residential campus sits at 140 NE 4th Avenue, one block off Atlantic Avenue and a five-minute walk to the ocean. For residents of Pineapple Grove, Lake Ida, Tropic Isle, the Beach District, and Osceola Park, admission does not require leaving the neighborhoods, physicians, and daily geography that already anchor recovery capital. Care starts locally, transitions in-house to residential without a handoff, and keeps the same clinical team from admission through discharge planning.

When medical detox is the clinical indication

Medical detox is indicated when the withdrawal syndrome carries meaningful medical risk or when unmanaged withdrawal would derail engagement with the next phase of care. Four presentations most reliably warrant an inpatient setting: alcohol use disorder with daily heavy consumption, benzodiazepine dependence at therapeutic or supratherapeutic doses, opioid use disorder with daily use, and polysubstance use combining any of the above. Stimulant-only withdrawal — cocaine, methamphetamine — is rarely medically dangerous, but supervised support during the acute crash phase reduces relapse risk and produces a cleaner baseline for residential treatment.

Level-of-care decisions follow the ASAM Criteria across all six dimensions: acute intoxication and withdrawal potential, biomedical conditions, emotional and behavioral conditions, readiness to change, relapse and continued-use potential, and recovery environment. A client with mild withdrawal risk and a stable environment may be appropriate for ambulatory management; a client with a history of complicated alcohol withdrawal — seizures, delirium tremens, autonomic instability — or an active benzodiazepine taper requires the 24/7 medical setting that a residential detox unit provides.

Prior withdrawal history matters. Each successive unmanaged withdrawal tends to be worse than the last, a kindling effect documented across alcohol and benzodiazepine dependence. A client whose last home detox produced a seizure is not a candidate for another home detox.

Symptom-triggered protocols using validated withdrawal scales

The Clinical Institute Withdrawal Assessment for Alcohol, revised — CIWA-Ar — scores ten symptom domains including nausea, tremor, paroxysmal sweats, anxiety, agitation, tactile and auditory disturbances, visual disturbances, headache, and orientation. Trained nursing runs the scale at defined intervals; benzodiazepine dosing is administered when the total score crosses treatment threshold rather than on a fixed schedule. Symptom-triggered dosing reduces cumulative benzodiazepine exposure, shortens median length of stay, and produces cleaner withdrawal trajectories than fixed-dose lorazepam or chlordiazepoxide taper.

The Clinical Opiate Withdrawal Scale — COWS — applies the same logic to opioid withdrawal, scoring pulse, sweating, restlessness, pupil size, bone and joint aches, GI upset, tremor, yawning, anxiety, and gooseflesh. Buprenorphine induction is timed to a COWS threshold that confirms sufficient withdrawal to avoid precipitated withdrawal on the first dose. Adjunctive medications — clonidine for autonomic symptoms, ondansetron for nausea, loperamide for GI, gabapentin or hydroxyzine for anxiety and sleep — are layered as symptoms dictate.

Symptom-triggered protocols are standard-of-care and they only work when bedside staffing supports frequent, accurate scale administration. Fixed-dose taper regimens are simpler to run with lean nursing but they systematically over- or under-medicate. RECO Island staffs to the protocol, not the protocol to the census.

Medical evaluation and comorbidity management

Every admission includes a full history and physical, medication reconciliation, and a laboratory panel appropriate to the substance and clinical picture — typically CBC, CMP, LFTs, TSH, urine drug screen, urine pregnancy where indicated, and EKG where cardiovascular risk or QT-prolonging medications warrant it. Vital signs are monitored on a schedule tied to acuity. Abnormal labs are followed to resolution rather than filed.

Chronic medical conditions do not pause during detox. Hypertension, type 2 diabetes, hepatitis C, cardiac disease, seizure disorder, and untreated infection are managed concurrently with withdrawal. Home medications are reconciled at admission and either continued, held, or substituted based on interaction with the detox protocol — a client on chronic clonazepam does not stop clonazepam on day one; the taper is folded into the withdrawal protocol. Nutrition, hydration, and thiamine (banana bag or oral) are actively supported. Sleep is treated as a clinical variable, not a comfort request.

Psychiatric comorbidity is assessed early with PHQ-9, GAD-7, and where indicated the ASRS or YBOCS. Acute psychiatric decompensation during detox is common and expected; medications such as sertraline, buspirone, quetiapine, olanzapine, or aripiprazole are initiated when clinically indicated rather than deferred to a later phase of care.

The transition into residential without gaps

The single most consequential moment in a detox stay is the day the client transitions out. Nationally, the highest-risk window for opioid overdose is the first two weeks after detox discharge, driven by lost tolerance meeting relapse. Detox that ends at a curb with a discharge paper and a list of referrals is a failure mode, not a treatment plan.

At RECO Island, the transition from medical detox into residential treatment happens within the same organization, on the same campus, with the same primary therapist assignment carrying forward. There is no transfer packet negotiated between providers, no waitlist to survive, and no clinical information dropped between electronic health records. The treatment plan started at admission continues on day one of residential — the same CBT, DBT, EMDR, MI, or ACT modalities matched to the same diagnostic formulation.

Medication-assisted treatment decisions — buprenorphine or naltrexone for opioid use disorder, naltrexone or acamprosate for alcohol use disorder — are made in detox and continued into residential without a re-induction. Family contact, insurance authorization, and outpatient step-down planning begin during detox, not after.

What to expect on the first day

Admission begins with a phone or in-person clinical assessment covering substance-use history, prior withdrawal complications, medical and psychiatric history, current medications, and insurance verification. If the assessment indicates a medical detox level of care, admission can typically be scheduled same-day or next-day. Clients arrive with a small bag of personal items; phones are held during the first 24-72 hours of acute withdrawal and returned based on clinical stability.

The first 24 hours focus on stabilization: baseline labs and EKG drawn, CIWA-Ar or COWS scoring initiated, IV fluids and thiamine administered as indicated, primary medications started, and a private room assigned. A physician evaluates within hours of arrival. By day two or three, most clients are past the acute withdrawal peak, sleeping, and beginning to participate in orientation groups with a primary therapist assigned and the residential-phase treatment plan being drafted with client input.

Insurance and admissions from Delray Beach

RECO Island contracts with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS plans for detox and residential levels of care. Verification of benefits is completed before admission — deductible, coinsurance, out-of-pocket maximum, and prior-authorization requirements are documented in writing rather than left ambiguous. Utilization review during the stay is handled by the RECO Island team, not the client.

For Delray Beach residents, the practical logistics are simple: the campus is inside city limits, roughly 0 miles from Pineapple Grove, Lake Ida, Tropic Isle, Osceola Park, and the Beach District. A family member, friend, or ride-share can bring the client directly to the intake entrance. Admissions is staffed 24/7 and clients arriving in acute withdrawal are triaged immediately.

Serving residents of: Pineapple Grove, Lake Ida, Tropic Isle, Beach District, Osceola Park.